Cytogen Statistics

Total Valuation

Cytogen has a market cap or net worth of KRW 90.66 billion. The enterprise value is 67.48 billion.

Market Cap	90.66B
Enterprise Value	67.48B

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Cytogen has 23.07 million shares outstanding. The number of shares has increased by 17.66% in one year.

Current Share Class	23.07M
Shares Outstanding	23.07M
Shares Change (YoY)	+17.66%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	18.32%
Owned by Institutions (%)	0.03%
Float	10.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.77
PB Ratio	1.94
P/TBV Ratio	2.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.06
EV / Sales	4.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.96

Financial Position

The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.32.

Current Ratio	3.41
Quick Ratio	3.18
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-1.55
Interest Coverage	-4.52

Financial Efficiency

Return on equity (ROE) is -32.03% and return on invested capital (ROIC) is -9.13%.

Return on Equity (ROE)	-32.03%
Return on Assets (ROA)	-8.11%
Return on Invested Capital (ROIC)	-9.13%
Return on Capital Employed (ROCE)	-16.69%
Revenue Per Employee	314.23M
Profits Per Employee	-332.24M
Employee Count	50
Asset Turnover	0.21
Inventory Turnover	10.94

Taxes

Income Tax	-702.37M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.83% in the last 52 weeks. The beta is -0.18, so Cytogen's price volatility has been lower than the market average.

Beta (5Y)	-0.18
52-Week Price Change	-56.83%
50-Day Moving Average	3,830.60
200-Day Moving Average	5,370.35
Relative Strength Index (RSI)	55.14
Average Volume (20 Days)	280,687

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cytogen had revenue of KRW 15.71 billion and -16.61 billion in losses. Loss per share was -728.77.

Revenue	15.71B
Gross Profit	4.08B
Operating Income	-9.68B
Pretax Income	-17.31B
Net Income	-16.61B
EBITDA	-7.36B
EBIT	-9.68B
Loss Per Share	-728.77

Full Income Statement

Balance Sheet

The company has 38.62 billion in cash and 15.05 billion in debt, giving a net cash position of 23.58 billion or 1,022.07 per share.

Cash & Cash Equivalents	38.62B
Total Debt	15.05B
Net Cash	23.58B
Net Cash Per Share	1,022.07
Equity (Book Value)	46.65B
Book Value Per Share	2,005.01
Working Capital	32.78B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.08 billion and capital expenditures -611.94 million, giving a free cash flow of -9.69 billion.

Operating Cash Flow	-9.08B
Capital Expenditures	-611.94M
Free Cash Flow	-9.69B
FCF Per Share	-420.13

Full Cash Flow Statement

Margins

Gross margin is 25.99%, with operating and profit margins of -61.64% and -105.73%.

Gross Margin	25.99%
Operating Margin	-61.64%
Pretax Margin	-110.19%
Profit Margin	-105.73%
EBITDA Margin	-46.83%
EBIT Margin	-61.64%
FCF Margin	n/a

Dividends & Yields

Cytogen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.66%
Shareholder Yield	n/a
Earnings Yield	-18.32%
FCF Yield	-10.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 28, 2022. It was a forward split with a ratio of 3.

Last Split Date	Sep 28, 2022
Split Type	Forward
Split Ratio	3

Scores

Cytogen has an Altman Z-Score of 2.68 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.68
Piotroski F-Score	4